When IsoRay, Inc. (NYSEMKT:ISR) plunged into the field of developing treatment solutions for cancer, there was no telling how long it would take to bring a product to the market and how that product might change the fortunes of the company. But following recent developments, it is not easy to doubt that the company is poised for big harvest in cancer treatment. IsoRay, Inc. (NYSEMKT:ISR) stock opened today at $3.08 and is currently trading at $3.01. The stock showed a positive weekly performance of 43.64%.
Harwood Feffer LLP is investigating potential claims against the board of directors of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) concerning the proposed acquisition of the Company by private equity firm Mallinckrodt Plc. Under the terms of the proposed transaction Questcor shareholders will receive $86.08 per common share owned. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $80.79, in current trading session and currently is at $80.26, by loosing -0.36%.The 52 week range of $26.80-$85.11. Company’s market capitalization is $4.85 billion.
Express Scripts Holding Co. (ESRX), a pharmacy benefit manager that handles more than 1 billion prescriptions annually in the U.S., is ratcheting up its effort to force Gilead Sciences Inc. (NASDAQ:GILD) to cut the $84,000 price of its new hepatitis C pill Sovaldi. Gilead Sciences, Inc. (NASDAQ:GILD) stock is currently trading at $70.28 .The EPS of the stock is 1.82. Company’s market capitalization is $108.05 billion.
Celgene Corporation (NASDAQ:Celgene) announced that it will host a conference call and live audio webcast onThursday, April 24, 2014 at 9:00 a.m. ET, to discuss its Q1 2014 financial and operational results. The Company informed that the webcast can be accessed on Celgene’s website. Celgene Corporation (NASDAQ:CELG) stock opened the session at $139.22, and now is at $137.26. The 52 week range of the CELG stock remained $110.53-$174.66 and the day range was $136.81-$139.68.